REMINDER 📅 Live Webinar @ 9:00 PM EST ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [StocksToTrade Live]( Unlock Tomorrow's Trading Opportunities, TONIGHT! Join us for a LIVE trading workshop @ 9:00 PM EST tonight and prepare for a week of successful trading! This evening, you will learn to analyze trends, forecast hot sectors, and compile a killer watchlist using our cutting-edge software and breakthrough, 3-step trading system. If tonight's after hours action is any indicator, tomorrow could get interesting… Earlier tonight, Senti Biosciences (NASDAQ: SNTI) was sent soaring after announcing a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd., which could be worth up to $156 MILLION in milestone payments and royalties (4X SNTI's entire market cap!). We're anticipating this ticker to be on our premiere algorithm, Oracle, tomorrow morning… Here is tonight's agenda: - Oracle Revealed: An in-depth exploration of our top-notch algorithm.
- Oracle in Play: Leverage Oracle's predictions for tomorrow's opening bell.
- Market's Big Moves: Revisiting VERB for 16% and CDIO for 58%! Past performance does not indicate future results. [Enter the LIVE Webinar Room NOW.]( PLUS: Want our analyst's game plans for tomorrow? Attendees will get a sneak peek at tonight's brand new watchlist… Our trading workshop is about to begin, act now or miss out! [Sign in immediately.]( Plan, prepare, and prosper, StocksToTrade Team   [Click Here to Unsubscribe]( 13809 Research Boulevard, Suite 500, Austin, TX 78750 This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com